AIRS reports Dr. Aaron Rollins resigns from board and chair role

Rhea-AI Filing Summary

AirSculpt Technologies (AIRS) announced a leadership change. On November 4, 2025, Dr. Aaron Rollins resigned as executive chairman and as a member of the board of directors, effective the same day.

The company stated that Dr. Rollins’ resignation was not due to any disagreements with the company, its management, or the board on matters related to operations, policies, or practices. The filing lists no additional board or management changes or interim appointments.

Insights

Corporate governance analyst

Board resignation disclosed; no stated dispute or policy rift.

AirSculpt Technologies reported that Dr. Aaron Rollins resigned as executive chairman and director effective November 4, 2025. The company explicitly notes the departure was not due to disagreements on operations, policies, or practices, which reduces the likelihood of immediate governance conflict signals from this event alone.

The absence of disclosed replacements or role reassignments in the excerpt means short‑term governance continuity depends on existing board structure and committee leadership. As described, this is a discrete leadership change without accompanying strategic, financial, or policy shifts in the text.

Subsequent filings may provide additional detail on board composition or any interim arrangements if applicable. Based on the disclosed facts, market impact is uncertain and will hinge on future governance updates.

false 0001870940 0001870940 2025-11-04 2025-11-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT 

Pursuant to Section 13 or 15(d) 

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 4, 2025

AirSculpt Technologies, Inc. 

(Exact name of Registrant as Specified in Its Charter)

Delaware (State or Other Jurisdiction of Incorporation)	001-40973 (Commission File Number)	87-1471855 (IRS Employer Identification No.)
1111 Lincoln Road, Suite 802 Miami Beach, Florida		33139
(Address of Principal Executive Offices)		(Zip Code)

(786) 709-9690

(Registrant’s Telephone Number, Including Area Code)

Not applicable 

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class:		Trading Symbol(s):		Name of Exchange on Which Registered:
Common Stock, $0.001 par value per share		AIRS		The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 4, 2025, Dr. Aaron Rollins resigned as executive chairman of the board of directors (the “Board”) of AirSculpt Technologies, Inc. (the “Company”) and as a member of the Board, effective as of November 4, 2025. Dr. Rollins’ resignation was not due to any disagreements between him and the Company, its management, or the Board on any matter relating to the Company’s operations, policies or practices.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.	Description
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 5, 2025
	AirSculpt Technologies, Inc.
	By:	/s/ Dennis Dean
		Name: Dennis Dean
		Title: Chief Financial Officer

[Signature Page to the Form 8-K]

FAQ

What did AirSculpt Technologies (AIRS) disclose in its 8-K?

Dr. Aaron Rollins resigned as executive chairman and as a board member, effective November 4, 2025.

Was Dr. Aaron Rollins’ resignation from AIRS due to a disagreement?

No. The company stated it was not due to any disagreements with the company, management, or the board.

When did the AIRS board resignation take effect?

The resignation was effective November 4, 2025.

What positions did Dr. Aaron Rollins hold at AirSculpt (AIRS)?

He served as executive chairman of the board and as a member of the board of directors.

Did AirSculpt (AIRS) name a successor in this filing?

The excerpt does not disclose any successor or interim appointment.

What exchange does AIRS trade on and under what symbol?

AIRS trades on The Nasdaq Global Market under the symbol AIRS.